Agreed, out licencing whilst keeping ownership is what we want. Especially for helping Merck with their patent extensions for Keytruda with combined EFTI therapy. Huge news today as you said we are being sought out to help improve/resurrect their trial. Bring on June 4 Data. Exciting time to hold IMM.
Ann: Immutep enters New Collaboration with Merck KGaA for Efti, page-8
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.030(9.68%) |
Mkt cap ! $494.5M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 35.0¢ | 32.0¢ | $4.857M | 14.38M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 142807 | 2 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |